Skip to content
10-Q

Quarterly Report

SIGHT SCIENCES, INC. SGHT

0001193125-26-209116

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 54.41M sh
Shares Diluted Q1 2026 · Mar 31, 2026 53.94M sh
Shares Diluted Q1 2026 · Mar 31, 2025 51.29M sh
Capex Q1 2026 · Mar 31, 2026 $60K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$7.03M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$11.61M
Long Term Debt Q1 2026 · Mar 31, 2026 $36.74M
Long Term Debt Q1 2026 · Dec 31, 2025 $40.3M
Short Term Debt Q1 2026 · Mar 31, 2026 $3.8M
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $84.96M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $91.97M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $108.77M
Stockholders Equity Q1 2026 · Mar 31, 2026 $53.9M
Stockholders Equity Q1 2026 · Dec 31, 2025 $63.94M
Stockholders Equity Q1 2026 · Mar 31, 2025 $77.63M
Stockholders Equity Q1 2026 · Dec 31, 2024 $87.52M
Current Liabilities Q1 2026 · Mar 31, 2026 $18.16M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.03M
Total Liabilities Q1 2026 · Mar 31, 2026 $55.8M
Total Liabilities Q1 2026 · Dec 31, 2025 $51.36M
Current Assets Q1 2026 · Mar 31, 2026 $106.51M
Current Assets Q1 2026 · Dec 31, 2025 $112.73M
Total Assets Q1 2026 · Mar 31, 2026 $109.7M
Total Assets Q1 2026 · Dec 31, 2025 $115.3M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.24
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.28
Eps Basic Q1 2026 · Mar 31, 2026 −$0.24
Eps Basic Q1 2026 · Mar 31, 2025 −$0.28
Sga Expense Q1 2026 · Mar 31, 2026 $26.85M
Sga Expense Q1 2026 · Mar 31, 2025 $24.52M
Rd Expense Q1 2026 · Mar 31, 2026 $2.55M
Rd Expense Q1 2026 · Mar 31, 2025 $4.43M
Net Income Q1 2026 · Mar 31, 2026 −$12.98M
Net Income Q1 2026 · Mar 31, 2025 −$14.15M
Operating Income Q1 2026 · Mar 31, 2026 −$12.41M
Operating Income Q1 2026 · Mar 31, 2025 −$13.86M
Gross Profit Q1 2026 · Mar 31, 2026 $16.98M
Gross Profit Q1 2026 · Mar 31, 2025 $15.09M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $2.72M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $2.41M
Revenue Q1 2026 · Mar 31, 2026 $19.7M
Revenue Q1 2026 · Mar 31, 2025 $17.51M